Gastric Inhibitory Polypeptide Increases Mesenteric Blood Flow
- 1 July 1978
- journal article
- research article
- Published by Frontiers Media SA in Experimental Biology and Medicine
- Vol. 158 (3) , 446-448
- https://doi.org/10.3181/00379727-158-40222
Abstract
Gastric inhibitory polypeptide (GIP) induces dose-dependent increases in superior mesenteric blood flow in the anesthetized cat. There was no concomitant change in systemic arterial pressure or in femoral blood flow indicating a specific decrease in mesenteric vascular resistance.This publication has 3 references indexed in Scilit:
- MECHANISMS OF LOCAL VASODILATION WITH HYPERTONIC GLUCOSE IN JEJUNUM1972
- VASCULAR HYPERTONICITY . A MECHANISM FOR VASODILATATION IN DUMPING SYNDROME1966
- Effects of Ingestion of Hyperosmotic Glucose Solution on the Splanchnic Circulation in Normal Subjects and in Partially Gastrectomized Patients Reacting with Circulatory CollapseScandinavian Journal of Clinical and Laboratory Investigation, 1961